Clinical Trial Update: Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated MK0653A in combination with simvastatin for cholesterol lowering in patients with hypercholesterolemia and atherosclerotic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Hypercholesterolemia

Drugs mentioned

• MK0653A
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Atherosclerotic Disease | Phase 3 | Status: COMPLETED